Suchergebnisse - "Yin, Shu-Yi"

PubPharm (28)

1

Papillary renal neoplasm with reverse polarity : an observational study of histology, immunophenotypes, and molecular variation

enthalten in: Translational andrology and urology | 2024

von Han, H. | Yin, S. | Song, R. | +4

2

A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent : A Multicenter Study

enthalten in: Journal of hepatocellular carcinoma | 2024

von Wang, H. | Chen, J. | Yin, S. | +5

3

Use of benzofuran lignans to induce IL-25 expression and suppress mammary tumor metastasis

enthalten in: Europäisches Patentamt | 2021

von YANG NING-SUN | KUO YUEH-HSIUNG | YIN SHU-YI | +1

4

METHOD AND DEVICE FOR CONSTRUCTING DIGITAL DISEASE MODULE

enthalten in: Europäisches Patentamt | 2021

von YIN SHU-YI | PAN I-HONG

5

USE OF BENZOFURAN LIGNANS TO INDUCE IL-25 EXPRESSION AND SUPPRESS MAMMARY TUMOR METASTASIS

enthalten in: Europäisches Patentamt | 2020

von YANG NING-SUN | KUO YUEH-HSIUNG | YIN SHU-YI | +1

6

Transcriptomic analysis reveals a controlling mechanism for NLRP3 and IL-17A in dextran sulfate sodium (DSS)-induced colitis

enthalten in: Scientific reports | 2018

von Lin, T. | Yin, S. | Hsiao, P. | +2

7

Correction : Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1

enthalten in: Oncotarget | 2018

von Yin, S. | Efferth, T. | Jian, F. | +6

ErratumFor: Oncotarget. 2016 Jul 12;7(28):43629-43653. - PMID 27248319

8

USE OF BENZOFURAN LIGNANS TO INDUCE IL-25 EXPRESSION AND SUPPRESS MAMMARY TUMOR METASTASIS

enthalten in: Europäisches Patentamt | 2017

von YANG NING-SUN | KUO YUEH-HSIUNG | YIN SHU-YI | +1

9

Phytochemicals Approach for Developing Cancer Immunotherapeutics

enthalten in: Frontiers in pharmacology | 2017

von Yin, S. | Yang, N. | Lin, T.

10

Immunogenicity of mammary tumor cells can be induced by shikonin via direct binding-interference with hnRNPA1

enthalten in: Oncotarget | 2016

von Yin, S. | Efferth, T. | Jian, F. | +6

ErratumIn: Oncotarget. 2018 Aug 14;9(63):32271. - PMID 30181816